Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
<i>Background and Objectives:</i> Tadalafil for treatment of fetal growth restriction (FGR) or preeclampsia is given once a day orally. The drug kinetics of tadalafil were investigated to determine the ideal dosage to promote uterine blood flow. <i>Materials and Methods:</i>...
Main Authors: | Hiroaki Tanaka, Shintaro Maki, Shoichi Magawa, Masafumi Nii, Kayo Tanaka, Kenji Ikemura, Kuniaki Toriyabe, Tomoaki Ikeda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/10/708 |
Similar Items
-
Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial
by: Shintaro Maki, et al.
Published: (2019-06-01) -
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
by: Kyoka Tsuchiya, et al.
Published: (2020-12-01) -
Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction
by: Shintaro Maki, et al.
Published: (2020-05-01) -
EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT
by: Firas Shakir Attar
Published: (2015-12-01) -
The use of tadalafil on demand in specific categories of patients
by: S. I. Gamidov, et al.
Published: (2018-12-01)